When newborn babies open their eyes for the first time, they already possess nerve cells specialized in particular stimuli in the visual cortex of their brains – but these nerve cells are not…
Seeing is believing
How brains make sense of the visual worldIf your eyes deceive you, blame your brain. Many optical illusions work because what we see clashes with what we expect to see.That 3D movie?
Ophthalmic Pioneer Robert Sinskey, MD, Passes Away
“True happiness is not a feat lightly achieved, but I can honestly say that through my adventures, experiences, and relationships — thick and thin — I have found it.”
— A Life in Focus, Robert M. Sinskey, MD
World-renowned cataract surgeon Robe…
Imprimis Acquires Proprietary Compounded Conscious Sedation Formulations
Imprimis Pharmaceuticals has acquired the rights to novel proprietary sedation and analgesia/anesthesia formulations that are administered sublingually to block pain and sedate patients undergoing ocular and other surgical procedures, according to a ne…
Ocular Therapeutix Begins Enrollment for Phase 3 Clinical Trial for Dextenza
Ocular Therapeutix announced enrollment of the first patients in a phase 3 clinical trial to evaluate the safety and efficacy of Dextenza (sustained-release dexamethasone, 0.4 mg) for the treatment of allergic conjunctivitis, according to a company new…
Allergan to Acquire Aesthetic Drug Maker for $2.1 Billion
Allergan and Kythera Biopharmaceuticals, a company focused on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market, announced that they have entered into a definitive agreement under which A…